GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medacta Group SA (XSWX:MOVE) » Definitions » EV-to-EBIT
中文

Medacta Group (XSWX:MOVE) EV-to-EBIT : 37.85 (As of Apr. 24, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Medacta Group EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Medacta Group's Enterprise Value is CHF2,396.0 Mil. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF63.3 Mil. Therefore, Medacta Group's EV-to-EBIT for today is 37.85.

The historical rank and industry rank for Medacta Group's EV-to-EBIT or its related term are showing as below:

XSWX:MOVE' s EV-to-EBIT Range Over the Past 10 Years
Min: 22.51   Med: 43.16   Max: 104.93
Current: 37.85

During the past 9 years, the highest EV-to-EBIT of Medacta Group was 104.93. The lowest was 22.51. And the median was 43.16.

XSWX:MOVE's EV-to-EBIT is ranked worse than
76.99% of 465 companies
in the Medical Devices & Instruments industry
Industry Median: 19.86 vs XSWX:MOVE: 37.85

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Medacta Group's Enterprise Value for the quarter that ended in Dec. 2023 was CHF2,673.8 Mil. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF63.3 Mil. Medacta Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was 2.37%.


Medacta Group EV-to-EBIT Historical Data

The historical data trend for Medacta Group's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medacta Group EV-to-EBIT Chart

Medacta Group Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
Get a 7-Day Free Trial Premium Member Only 85.41 40.09 48.22 38.00 43.25

Medacta Group Semi-Annual Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 48.22 - 38.00 - 43.25

Competitive Comparison of Medacta Group's EV-to-EBIT

For the Medical Devices subindustry, Medacta Group's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medacta Group's EV-to-EBIT Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medacta Group's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Medacta Group's EV-to-EBIT falls into.



Medacta Group EV-to-EBIT Calculation

Medacta Group's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=2395.997/63.307
=37.85

Medacta Group's current Enterprise Value is CHF2,396.0 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF63.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group  (XSWX:MOVE) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Medacta Group's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=63.307/2673.767
=2.37 %

Medacta Group's Enterprise Value for the quarter that ended in Dec. 2023 was CHF2,673.8 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Medacta Group's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was CHF63.3 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Medacta Group EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Medacta Group's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Medacta Group (XSWX:MOVE) Business Description

Traded in Other Exchanges
Address
Strada Regina 34, Castel San Pietro, Ticino, CHE, 6874
Medacta Group SA is a Switzerland based company involved in developing, manufacturing and distributing orthopaedic and neurosurgical medical devices worldwide. The company offers solutions for Hip, Knee, Shoulder and Spine.